Specificity of xenoreactive anti-Galα1–3Gal IgM for α-galactosyl ligands

By Parker William   Lateef Jarama   Everett Mary Lou   Platt Jeffrey L.  

Glycobiology, Vol. 6, Iss. 5, 1996-07 ,pp. : 499-506

Oxford University Press

Access to resources Recommend Favorite

Transcriptional and posttranscriptional regulation of α1,3-galactosyltransferase in activated endothelial cells results in decreased expression of Galα1,3Gal

By Vanhove B.   Sébille F.   Cassard A.   Charreau B.   Soulillou J-P.  

Glycobiology, Vol. 8, Iss. 5, 1998-05 ,pp. : 481-487

Oxford University Press

Access to resources Recommend Favorite

Synthesis of α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R) on human tumor cells by recombinant α1,3galactosyltransferase produced in Pichia pastoris

By Chen Z.C.  

Glycobiology, Vol. 11, Iss. 7, 2001-07 ,pp. : 577-586

Oxford University Press

Access to resources Recommend Favorite

Xenotransplantation: in vitro analysis of synthetic α -galactosyl inhibitors of human anti-Gal α 1 → 3Gal IgM and IgG antibodies

By Rieben Robert   V.Bovin Nicolai  

Glycobiology, Vol. 10, Iss. 2, 2000-02 ,pp. : 141-148

Oxford University Press

Access to resources Recommend Favorite

Overexpression of the α2,6-Sialyltransferase, ST6Gal I, in a Low Metastatic Variant of a Murine Lymphoblastoid Cell Line Is Associated with Appearance of a Unique ST6Gal I mRNA

By Lo N-W.   dennis J.W.   Lau J.T.Y.  

Biochemical and Biophysical Research Communications, Vol. 264, Iss. 3, 1999-11 ,pp. : 619-621

Elsevier

Access to resources Recommend Favorite